Welcome to PsychU!

Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar 1 Disorder: The Role Of Long-Acting Injectable Antipsychotics

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar 1 Disorder: The Role Of Long-Acting Injectable Antipsychotics

This is a Virtual Event for PsychU members in D.C., Maryland, North Carolina, South Carolina and Virginia.

In “Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics,” the objectives of this presentation are to understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes, discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder, and review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder.

Featuring

Dennis-Sholler

Dennis Sholler, PhD (OPDC)

Clinical & Scientific Liaison

Amica-Simmons-Yon

Amica Simmons-Yon, PharmD, PhD (OPDC)

Clinical & Scientific Liaison

Miranda-Fisher

Miranda Fisher, PhD (OPDC)

Clinical & Scientific Liaison

Speakers Dennis Sholler, PhD; Amica Simmons-Yon, PharmD, PhD; and Miranda Fisher, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Log in to register

Already registered?

Already registered?

Use this tool to manage your registration.

Related Resources